How might co-financing make structural interventions more attractive for the HIV sector? This presentation explores methods and decision rules for allocating resources to structural interventions.
The presentation argues that the measures used by funders and policy-makers concerned about low HIV-specific cost-effectiveness don’t do justice to the multiple outcomes of structural interventions. In a co-financing scenario, cost effectiveness should be measured according to the HIV sector’s proportional contribution.
Remme, M.; Vassall, A.; Lutz, B.; Luna, J.; Watts, C. Value for money of structural interventions: going beyond HIV-only cost-effectiveness analysis. Presented at International AIDS Economics Network Pre-Conference, 20-21 July 2012, Washington, D.C.. (2012) 13 pp.